01:17 PM EST - BELLUS Health Inc. : Announced that it has received from Taro Pharmaceuticals Inc. a milestone payment of $400,000 in relation to the sale of its wholly-owned subsidiary Thallion Pharmaceuticals Inc. in March 2017. BELLUS Health Inc.
shares T.BLU are trading unchanged at $0.40.
